Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China flag China · Delayed Price · Currency is CNY
9.50
+0.17 (1.82%)
Jul 30, 2026, 11:29 AM CST
Market Cap4.10B -13.8%
Revenue (ttm)1.79B +1.9%
Net Income306.52M +12.2%
EPS0.70 +12.9%
Shares Out 439.08M
PE Ratio13.33
Forward PE11.24
Dividend0.45 (4.93%)
Ex-Dividend DateMay 29, 2026
Volume7,125,100
Open9.30
Previous Close9.33
Day's Range9.27 - 9.56
52-Week Range8.64 - 13.50
Beta0.29
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets;... [Read more]

Sector Healthcare
Founded 2000
Employees 1,868
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603998
Full Company Profile

Financial Performance

In 2025, SHA:603998's revenue was 1.75 billion, a decrease of -1.75% compared to the previous year's 1.78 billion. Earnings were 306.39 million, an increase of 20.05%.

Financial Statements